View Author
receptor somatostatin peptide tumor uptake octreotide binding patient study activity analogue tumour tissue imaging radioactivity effect internalization breeman 68 ga injection result cancer tumours liver control radionuclide scintigraphy jong m therapy concentration generator blood somatostatin receptors amount krenning ep radioligand lamberts swj bakker wh treatment 68 ge activity radiolabelled administration receptor-positive krenning eluate figure analog in-dtpa-d-phe kidney lambert experiment breeman wap group bakker application ratio -160 table value animal substance visser tj increase visser kooij ppm substance p reubi unlabelled organ stability volume distribution kwekkeboom dj pancreas dtpa-d-phe koper jw elution fraction metastase subtype
10 Most Recent Publications
|
Scaled-up radiolabelling of DOTATATE with
68Ga eluted from a SnO
2-based
68Ge/
68Ga generator
(Article)
Rossouw, D.D. Breeman, W.A.P. |
2012-01-01
|
|
Speciation of no-carrier-added 68Ga prior to its labeling for PET imaging
(Article)
Sen, K. Breeman, W.A.P. Wolterbeek, H.Th. |
2011-10-19
|
|
Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607
(Article)
Ocak, M. Helbok, A. Decristoforo, C. Rangger, C. Peitl, P.K. Nock, B.A. Morelli, G. Eek, A. Sosabowski, J.K. Breeman, W.A.P. Reubi, J.C. |
2011-08-01
|
|
Comparison of the binding and internalization properties of 12 DOTA-coupled and
111In-labelled CCK2/gastrin receptor binding peptides: A collaborative project under COST Action BM0607
(Article)
Aloj, L. Aurilio, M. Sosabowski, J.K. Breeman, W.A.P. Blois, E. de Koelewijn, S. Melis, M.L. Waser, B. Beetschen, K. Reubi, J.C. Jong, M. de Rinaldi, V. D'ambrosio, L. Tesauro, D. Peitl, P.K. Maina, T. Mansi, R. Guggenberg, E. von Joosten, L. |
2011-08-01
|
|
Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts
(Article)
Schroeder, R.P.J. Weerden, W.M. van Jong, M. de Krenning, E.P. Bangma, C.H. Berndsen, S.C. Grievink-De Ligt, C.H. Groen, H.C. Reneman, S. Blois, E. de Breeman, W.A.P. |
2011-07-01
|
|
68Ga-labeled DOTA-peptides and
68Ga-labeled radiopharmaceuticals for positron emission tomography: Current status of research, clinical applications, and future Perspectives
(Article)
Breeman, W.A.P. Blois, E. de Sze Chan, H. Konijnenberg, M. Kwekkeboom, D.J. Krenning, E.P. |
2011-07-01
|
|
Effect of interferon-a treatment on [68Ga-DOTA,Tyr3,Thre8] octreotide uptake in CA20948 tumors: A small-animal PET study
(Article)
Hanin, F.-X. Pauwels, S. Bol, A. Melis, M.L. Breeman, W.A.P. Jong, M. de Jamar, F. |
2011-04-01
|
|
Reduction of 68Ge activity containing liquid waste from 68Ga PET chemistry in nuclear medicine and radiopharmacy by solidification
(Article)
Blois, E. de Chan, H.S. Roy, K. Krenning, E.P. Breeman, W.A.P. |
2011-04-01
|
|
Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides
(Article)
Blois, E. de Sze Chan, H. Naidoo, C. Prince, D. Krenning, E.P. Breeman, W.A.P. |
2011-02-01
|
|
A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues
(Article)
Schroeder, R.P.J. Müller, C. Reneman, S. Melis, M.L. Breeman, W.A.P. Blois, E. de Bangma, C.H. Krenning, E.P. Weerden, W.M. van Jong, M. de |
2010-07-01
|
